Invesco Ltd. has filed an amended Schedule 13G reporting a passive ownership stake in BioLife Solutions Inc. common stock. Invesco may be deemed to beneficially own 3,932,191 shares, representing 8.2% of the outstanding common stock, held of record by its advisory clients.
Invesco reports sole voting power over 3,607,451 shares and sole dispositive power over all 3,932,191 shares, with no shared voting or dispositive power. The filing identifies Invesco Advisers, Inc. and Invesco Capital Management LLC as relevant subsidiaries, and notes that no individual has more than a 5% economic interest.
Invesco certifies that the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of BioLife Solutions.
Positive
None.
Negative
None.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
BioLife Solutions Inc
(Name of Issuer)
Common Stock
(Title of Class of Securities)
09062W204
(CUSIP Number)
12/31/2025
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
SCHEDULE 13G
CUSIP No.
09062W204
1
Names of Reporting Persons
Invesco Ltd.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
BERMUDA
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
3,607,451.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
3,932,191.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
3,932,191.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.2 %
12
Type of Reporting Person (See Instructions)
HC, IA
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
BioLife Solutions Inc
(b)
Address of issuer's principal executive offices:
3303 Monte Villa Parkway, Suite 310, Bothell, WA 98021
Item 2.
(a)
Name of person filing:
Invesco Ltd. ("Invesco Ltd.")
(b)
Address or principal business office or, if none, residence:
1331 Spring Street NW, Suite 2500, Atlanta, GA 30309
(c)
Citizenship:
Bermuda
(d)
Title of class of securities:
Common Stock
(e)
CUSIP No.:
09062W204
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
Invesco Ltd., in its capacity as a parent holding company to its investment advisers, may be deemed to beneficially own 3,932,191 shares of the Issuer which are held of record by clients of Invesco Ltd.
(b)
Percent of class:
8.2 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
3,607,451
(ii) Shared power to vote or to direct the vote:
0
(iii) Sole power to dispose or to direct the disposition of:
3,932,191
(iv) Shared power to dispose or to direct the disposition of:
0
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
However, no one individual has greater than 5% economic ownership. The shareholders of the Fund have the right to receive or the power to direct the receipt of dividends and proceeds from the sale of securities listed above.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
Invesco Advisers, Inc.
Invesco Capital Management LLC
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
What ownership stake does Invesco report in BioLife Solutions (BLFS)?
Invesco reports beneficial ownership of 3,932,191 BioLife Solutions common shares, representing 8.2% of the class. These shares are held of record by clients of Invesco’s advisory subsidiaries, with Invesco deemed a parent holding company under the Schedule 13G filing.
How much voting and dispositive power does Invesco have over BLFS shares?
Invesco reports sole voting power over 3,607,451 BioLife shares and sole dispositive power over 3,932,191 shares, with no shared voting or dispositive power. This means Invesco-controlled entities can vote most shares and decide on the disposition of all reported shares.
Is Invesco’s stake in BioLife Solutions (BLFS) considered passive or active?
Invesco certifies the position as passive, held in the ordinary course of business. The filing states the shares were not acquired and are not held to change or influence control of BioLife Solutions, consistent with a Schedule 13G, rather than activist, Schedule 13D, status.
Which Invesco subsidiaries are involved in holding BioLife Solutions (BLFS) shares?
The filing identifies Invesco Advisers, Inc. and Invesco Capital Management LLC as the relevant subsidiaries. These advisory entities hold BioLife Solutions shares on behalf of their clients, while Invesco Ltd. reports as the parent holding company under Schedule 13G rules.
Do any individual investors hold more than 5% of BioLife Solutions through Invesco?
The filing states that no one individual has greater than 5% economic ownership. The BioLife Solutions shares are held for multiple clients of Invesco’s funds and advisory accounts, so economic interests are spread across many underlying shareholders and beneficiaries.
What is the significance of the 8.2% ownership level in BLFS?
An 8.2% stake makes Invesco a significant institutional holder in BioLife Solutions. This level exceeds the 5% threshold that requires public disclosure on Schedule 13G, providing transparency about large institutional ownership in the company’s common stock.
